browser icon
You are using an insecure version of your web browser. Please update your browser!
Using an outdated browser makes your computer unsafe. For a safer, faster, more enjoyable user experience, please update your browser today or try a newer browser.

PAKEJ TERAPI METABOLIK VITAMIN B17

PAKEJ TERAPI METABOLIK VITAMIN B17 ialah gabungan beberapa supliment yang digunakan untuk merawat kanser tahap 3 dan empat atau jenis kanser kronik.

 

Kanser adalah pernyakit berkaitan gangguan metabolisma yang berkaitan dengan enzim semulajadi badan.Akibat dari gangguan2 ini akan menyebabkan sel2 sihat menjadi lemah dan seterusnya mencetuskan pelbagai penyakit yang berkaitan.


Penyelidik  kanser berpendapat kanser adalah penyakit berkaitam metabolisma tenaga dan pengurusannya mestilah menggunakan terapi yang menjurus kearah metabolisma tenaga.Kajian juga menunjukkan pengawalan dan pengurusan makanan yang berkesan akan membantu mencegah dan memperlahankan merebaknya sel2 kanser tertentu antaranya ialah kanser otak,kolon,penkerias,paru2 dan kanser prostat.Bukti yang terkumpul menunjukkan pengurusan sistem makan yang berkesan telah berjaya membantutkan tumbesaran pelbagai jenis tumor.


Olih itu terapi metabolik b17 disusun untuk mengembalikan fungsi enzim tertentu untuk membolihkan sel2 kanser dihapuskan secara semulajadi tanpa merosakkan sel2 yang sihat disekelilinnya.Vitamin B17 menjadi senjata utama memusnahkan perisai sel kanser ( protin ) untuk membolihkan imune system menghadam sel kanser.


Dan untuk memastikan imune sytem cukup kuat untuk berhadapan dengan sel2 kanser pengkerias mestilah berada ditahap terbaik dan mampu menjana enzim2 yang diperlukan.


Vitamin C adalah amat penting untuk memperteguhkan imune system.Sementara PROTXZYM yang direka khusus untuk membekalkan enzim trypsin dan chemotrypsin akan berperanan menyamai vitamin B17 dalam meruntuhkan tembok protin sel kanser.


Jus 19 jenis buah2an adalah vital untuk membina imune system dengan kadar segera kerana sesetengah pesakit kanser kronik terutamanya yang sedang menjalani rawatan kimoterapi hilang selera makan dan ini menghalang penjanaan zat2 penting untuk membina imun system.


Pesakit kanser memerlukan banyak air yang bebas klorin dan mengandungi kadar oksigen yang tinggi untuk proses pengnyahkan toksid dan membekalkan darah dengan oksigen yang cukup untuk mempercepatkan proses penyembuhan.Sel2 yang sihat amat memerlukan oksigen yang cukup untuk terus kuat dari diserang olih sel kanser.Menggunakan air berklorin akan memusnahkan  nutrin2 penting yang amat diperlukan olih badan dan proses penyembuhan akan menjadi lembab dan sia sia.


Bromalain diperbuat dari buah nenas dan amat penting kerana ia membantu sistem pencernaan dan memecahkan protin Maklumat mengenainya sila klick SINI


Adakalanya dikalangan pengamal terapi metabolik b17 menamakannya “TERAPI 21 HARI” kerana dalam tempoh itu pesakit sepatutnya telah menunjukkan tanda tanda penyembuhan.


Jika ada tanda2 penyembuhan utama ( susut pada tumor,penambahan berat badan atau hilang kesakitan ) pesakit sepatutnya meneruskan penggunaan suplimen2 hingga habis  dalam dos yang dikurangkan.Pakej ini adakalanya memerlukan pengubasuaian mengikut jenis kanser,alahan atau pesakit kanser ada penyakit penyakit sampingan yang lain.

PAKEJ 1

7 KOTAK ( 70 BOTOL ) INJECTION LEATERILE

AMIGDALINA

2 BOTOL 120 BIJI PIL BROMALAIN

1 BOTOL NOVODALIN B17 100 TABLETS –

1 BOTOL  PROTZYME FORTE ( ENZIM ) 200 TABLETS

1 KOTAK 4 BOTOL JUS 19JENIS BUAH2AN “MONAVIE”

1 PEKET SUNTIKAN VITAMIN C ( stok 1 bulan )

X 7 KOTAK @ 70 BOTOL -RM4900 

 

X 2 BOTOL BROMALAIN 500MG 180 TABLET – RM250 

 

X 1 BOTOL NOVODALIN 500 MG 100 TABLET – RM490 

 

X 1 BOTOL PROTXZYM 200 TABLET – RM400 

 

X 4 BOTOL JUS MONAVIE – RM500 

 

INJECTION VITAMIN C -RM300 

 

 

 

PAKEJ 2 ( PILIHAN )

1.   2  BOTOL ( 200 TABLET ) NOVADALIN B17

2.   2  BOTOL PIL BROMLAIN

3.   1  BOTOL PIL PROTXYZM

4.    8 BOTOL JUS 19 JENIS BUAH2AN

PS: SUPPLIMEN2 LAIN BERGANTUNG KEPADA  TAHAP KONDISI ORGAN2 LAIN SEPERTI BUAH PINGGANG,PERUT DAN PARU2


Most Cancer Patients Use Complementary Therapies

LONDON (Reuters) July 15, 2002 – More than half of all cancer patients are using complementary therapies to cope with the side effects of hospital-based therapies, according to a report published Sunday. Market consultant Datamonitor said as many as 60% of cancer patients in certain European countries, and 80% in the United States, used special diets, vitamin supplements, herbal remedies or acupuncture. It said European use of complementary and alternative medicines appeared highest in Germany where products such as mistletoe had become established folk remedies.

Datamonitor estimated the global market for complementary and alternative medicines used by cancer patients could be as high as $18 billion annually, rivaling the sales of many traditional pharmaceutical approaches.

The report warned that information published on Web sites about herbal remedies was not always accurate and advised patients to consult a physician before using them. “Some herbal products or diets can affect how prescription cancer drugs are absorbed, or can increase certain side effects of mainstream cancer therapies,” according to the report.

“Patients taking complementary medicines need to share their use of these products with their oncologist, for the patients’ safety and for the patients’ best chance of fighting cancer,” it added.

The report forecast that increased scientific studies of alternative medicines could lead to the discovery of new


drugs. Complementary medicine and pharmaceutical drug development could move closer to each other, perhaps resulting in novel therapies, new manufacturing companies and commercially successful partnerships.


Enzyme may Help Curb Disease


Jul. 19, 2002 (Ivanhoe Newswire) — New research shows an enzyme that corrects mutations in genes could be a key factor in reducing a person’s susceptibility to diseases such as hemophilia, cancer and cystic fibrosis.

Researchers from Cardiff University in Wales and the University of Edinburgh in Scotland have found the MBD4 enzyme could protect people from gene mutations that can lead to diseases.


Different combinations of genes are expressed in different cells. For example, a different combination of genes is expressed in heart cells as compared to liver cells. Researchers say mutations in these genes can lead to serious diseases, such as cancer. They say, although factors such as cigarette smoke and dietary habits may trigger genetic mutations, a lot of gene damage is caused simply by the natural chemistry that goes on in the human body. When a mutation occurs, the genes stop doing their “jobs” effectively.


Researchers say one in three genetic changes or mutations that causes disease in people can be attributed to methyl-groups. Methyl-groups work to shut down genes, but in doing so significantly increase the risk of genetic mutation. Researchers have found the MBD4 enzyme attempts to repair the damage caused by methyl-groups before they cause harm.


Alan Clarke, a researcher from Cardiff University, says, “It is very likely the MBD4 is a key defense against self-inflicted gene damage in humans.” In this study of lab animals, Professor Clarke and fellow researchers found mice lacking the MBD4 enzyme are up to three times more likely to have genetic mutations. Authors of the study conclude, “These findings suggest that human MBD4 plays a similarly important role in reducing inherited disease and cancer.”